Evidence map›Paper›PMID 38708149›Full record

ArticleIndian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion2024

Is There a Role for Growth and Differentiation Factor-15 in B-Cell Lymphoproliferative Neoplasms?

Danijela Agić, Velibor Čabarkapa, Ivana Milošević, Ivanka Perčić, Amir El Farra, Stanislava Nikolić, Borivoj Sekulić, Nada Vlaisavljević, Aleksandar Savić, Ivana Urošević and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Danijela AgićClinic for Hematology, University Clinical Center of Vojvodina, Novi Sad, Serbia.ORCID 0000-0003-1697-3045
Velibor ČabarkapaCenter for Laboratory Medicine, University Clinical Center of Vojvodina, Novi Sad, Serbia.
Ivana MiloševićClinic for Hematology, University Clinical Center of Vojvodina, Novi Sad, Serbia.
Ivanka PerčićClinic for Hematology, University Clinical Center of Vojvodina, Novi Sad, Serbia.
Amir El FarraClinic for Hematology, University Clinical Center of Vojvodina, Novi Sad, Serbia.
Stanislava NikolićCenter for Laboratory Medicine, University Clinical Center of Vojvodina, Novi Sad, Serbia.
Borivoj SekulićClinic for Hematology, University Clinical Center of Vojvodina, Novi Sad, Serbia.
Nada VlaisavljevićClinic for Hematology, University Clinical Center of Vojvodina, Novi Sad, Serbia.
Aleksandar SavićClinic for Hematology, University Clinical Center of Vojvodina, Novi Sad, Serbia.
Ivana UroševićClinic for Hematology, University Clinical Center of Vojvodina, Novi Sad, Serbia.
Stevan L PopovićClinic for Hematology, University Clinical Center of Vojvodina, Novi Sad, Serbia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Growth and differentiation factor-15 (GDF-15) correlates with worse outcome of many tumours and any cause mortality. Data about its role in lymphoproliferative neoplasms (LPN) are scarce. Our research aimed to reveal the correlation between GDF-15 and standard laboratory parameters of LPN activity, and to get insight into the possible value of this cytokine assessment in lymphoma patients. Prospective research included 40 patients treated for aggressive or indolent LPN, and 31 with indolent LPN on "watch and wait" regimen. Analyses were performed before and after treatment in treated patients and on two separate occasions in the "watch and wait" group. ELISA technique with R&D assays according to the manufacturer manual, from stored sera at - 70 °C was used for GDF-15 level measurement. Statistical analyses were performed by IBM SPSS Statistics 22 using descriptive and inferential statistics. As appropriate, differences between groups were assessed by two tailed Supplementary Information: The online version contains supplementary material available at 10.1007/s12288-023-01695-6.

Indexed as

Beta 2-microglobulinGrowth differentiation factor 15Lymphoproliferative disordersRisk assessment

Identifiers

PMID38708149
PMCPMC11065822

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.